Cardiol Therapeutics Inc.
Life sciences company focused on the research and clinical development of therapies for the treatment of heart disease
27 employees · est. 2017 · Canada
Corstasis Therapeutics
Advancing Options for Patients Suffering from Edema Associated with Congestive Heart Failure, Liver, and Kidney Disease
10 employees · est. 2018 · Henderson, United States
Cardiol Therapeutics Inc. is the older company (2017 vs 2018); Cardiol Therapeutics Inc. is the larger of the two.
Side-by-Side Comparison
| Metric | Cardiol Therapeutics Inc. | Corstasis Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2017 older | 2018 |
| Headquarters | ||
| Headquarters | Canada | Henderson, United States |
| Employees | ||
| Employees | 27 larger | 10 |
| Industry | ||
| Industry | Biotechnology, Life Sciences | Not tracked yet |
| Funding Stage | ||
| Funding Stage | Post Ipo Equity | Unknown |
| Total Funding | ||
| Total Funding | $78.62M | Not tracked yet |
| Funding Rounds | ||
| Funding Rounds | 4 | 1 |
| Services | ||
| Services | Not tracked yet | Intuitive outpatient therapeutic options, Fluid overload reduction |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients with congestive heart failure, Patients with liver disease, Patients with kidney disease, Home healthcare providers |
| Taxonomy | ||
| Taxonomy | Pharmaceutical Cannabinoids, Cannabidiol Products, Heart Disease Treatments, Acute Myocarditis, Heart Failure, Nanotechnologies, Medical Cannabinoids Sector, Anti-inflammatory Medications, Proprietary Formulations, Commercial Development, Medical Cannabinoids Market, Innovative Therapies, Nanotechnologies For Drug Delivery, Inflammatory Heart Disease, Pharmaceutical Development | Pharmaceutical Innovation, Outpatient Treatment, Edema Solutions, Congestive Heart Failure, Liver Disease, Kidney Disease, Cardiology, Nephrology, Heart Failure Management, Clinical Stage Company, Fluid Overload |
| Website | ||
| Website | cardiolrx.com | corstasis.com |
About Cardiol Therapeutics Inc.
Cardiol Therapeutics is a biotechnology startup founded in 2017 that is pioneering advanced cannabidiol solutions and heart disease treatments for a healthier future. The company specializes in creating pharmaceutical cannabidiol products and pioneering treatments for heart conditions, including acu...
About Corstasis Therapeutics
Corstasis Therapeutics, founded in 2018, is a clinical-stage pharmaceutical company based in the United States. The firm is focused on advancing innovative outpatient options for patients grappling with fluid overload, or edema, which is commonly associated with conditions like congestive heart fail...
We will tell you when either one moves
BounceWatch watches Cardiol Therapeutics Inc. and Corstasis Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Cardiol Therapeutics I... and Corstasis Therapeutics — by email.
Frequently Asked Questions
Compare Cardiol Therapeutics Inc. with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Cardiol Therapeutics Inc. on 12 Sep 2024, and Corstasis Therapeutics on 3 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
